Matthew Richard Moore - May 16, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Signature
/s/ Martin D. Auster, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/17/2024, 04:20 PM
Previous filing
May 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (Right to Buy) Award $0 +320K $0.00 320K May 16, 2024 Common Stock 320K $4.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 16, 2024.